Treatment of ventricular tachycardia in patients with heart failure

Current Cardiology Reports

Volumn 13, Issue 3, 2011, Pages 203-209

  Fong, Michael W ^a   Grazette, Luanda ^a   Cesario, David ^a   Cao, Michael ^a   Saxon, Leslie ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Ablation; Heart failure; Treatment; Ventricular assist device; Ventricular tachycardia

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; AZIMILIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; DOFETILIDE; DRONADERONE; ENCAINIDE; FLECAINIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIDOCAINE; METOPROLOL; MEXILETINE; MORACIZINE; PLACEBO; PROCAINAMIDE; PROPAFENONE; QUINIDINE; RANOLAZINE; SOTALOL; UNCLASSIFIED DRUG;

ARTICLE; CATHETER ABLATION; CLINICAL EFFECTIVENESS; DEFIBRILLATION; DEVICE THERAPY; DRUG EFFICACY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE PACING; HEART VENTRICLE TACHYCARDIA; HEMODYNAMIC MONITORING; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; SUDDEN DEATH; TREATMENT DURATION; TREATMENT PLANNING;

ANTI-ARRHYTHMIA AGENTS; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TACHYCARDIA, VENTRICULAR;

EID: 79955909529     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-011-0182-5     Document Type: Article

References (47)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121(7):e46-215.
2. Luu M, Stevenson WG, Stevenson LW, et al. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 1989;80:1675-80. (Pubitemid 20031698)
3. Doval HC, Nul DR, Grancelli HO, et al. Nonsustained ventricular tachycardia in severe heart failure: independent marker of increased mortality due to sudden death. Circulation. 1996;94(12):3198-203. (Pubitemid 26427487)
4. Maskin CS, Siskind SJ, LeJemtel TH. High prevalence of nonsustained ventricular tachycardia in severe congestive heart failure. Am Heart J. 1984;107:896-901. (Pubitemid 14100840)
5. Packer M. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation. 1992;85:I50-6.
6. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933-40. (Pubitemid 26428217)
7. Buxton A, Lee K, Fisher J, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882-90.
8. Myerburg RJ, Reddy V, Castellanos A. Indications for implantable cardioverter-defibrillators based on evidence and judgment. J Am Coll Cardiol. 2009;54(9):747-63. This article is particularly useful to the reader because it thoroughly reviews the evidence behind ICD use for primary and secondary prevention, as well as rare disorders. The authors critically analyze the major studies and point out the limitations in trial design and data interpretation. The authors also discuss the economic impact and issues related to risk stratification.
9. Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359(10):1009-17.
10. Sweeney MO. The contradiction of appropriate shocks in primary prevention ICDs: increasing and decreasing the risk of death. Circulation. 2010;122(25):2638-41.
11. Saxon L, Hayes DL, Gilliam FR, et al. Long term outcome after ICD and CRT implantation and influence of remote device follow up. Circulation. 2010;122:2359-67. This article presented a study of the largest series of patients followed chronically with ICD and cardiac resynchronization therapy-defibrillator devices, most of whom were implanted for primary prevention indications in the setting of heart failure, showing survivals markedly better if devices are followed on a remote network.
12. Godemann F, Butter C, Lampe F, et al. Determinants of the quality of life (QoL) in patients with an implantable cardioverter/defibrillator (ICD). Qual Life Res. 13(2):411-6.
13. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225-37. (Pubitemid 40110811)
14. Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357(26):2657-65.
15. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2006;48(5):1064-108.
16. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med. 1991;324(12):781-8.
17. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XLrandomized Intervention trial in congestive heart failure (MERIT-HF). Lancet. 1999;353:2001-7.
18. Lechat P, Brunhuber K, Hofmann R, et al. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomized trial. Lancet. 1999;353:9-13. (Pubitemid 29037695)
19. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651-8. (Pubitemid 32479962)
20. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomized trial. Lancet. 2001;357:1385-90. (Pubitemid 32455364)
21. Dorval HC, Nul DR, Grancelli HO, et al. Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet. 1994;344:493-8. (Pubitemid 24261565)
22. Deedwania PC, Singh BN, Ellenbogen K. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). Circulation. 1998;98:2574-9. (Pubitemid 29001197)
23. Piccini JP, Berger JS, O'Connor CM. Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials. Eur Heart J. 2009;30:1245-53.
24. Korber L, Torp-Peterson C, McMurray JJV, et al. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med. 2008;358:2678-87. (Pubitemid 351860860)
25. Waldo AL, Camm AJ, de Ruyter H, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet. 1996;348:7.
26. Dorian P, Borggrefe M, Al-Khalidi HR, on behalf of the SHock Inhibition Evaluation with azimiLiDE(SHIELD) investigators, et al. Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation. 2004;110:3646-54.
27. Hohnloser S, Dorian P, Al-Khalidi H, Brum J, Tatla D, Pratt C. Electrical storms in patients with implantable defibrillators: results from Shock Inhibition Evaluation with Azimilide (SHIELD) trial. Circulation. 2005;112:II-492.
28. Das MK, Zipes DP. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention. J Cardiovasc Pharmacol. 2010;55:438-49. This review article provides an excellent and comprehensive overview of the current pharmacologic therapy for ventricular arrhythmia and sudden death prevention. The article outlines the key studies related to each drug and serves as a useful reference for the reader.
29. Morrow DA, Scirica BM, Karwatowska-Prokopczuk E, et al. Effects of ranolazine on recurrent cardiovascular events in patients with non-st-elevation acute coronary syndromes. JAMA. 2007;297(16):1775-83.
30. Aliot EM, Stevenson WG, Almendral-Garrote JM, et al. EHRA/HRS expert consensus on catheter ablation of ventricular arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm. 2009;6(6):886-933.
31. Stevenson WG, Soejima K. Catheter ablation for ventricular tachycardia. Circulation. 2007;115:2750-60. (Pubitemid 46842792)
32. Cesario D, Saxon L, Cao M et al. Ventricular tachycardia in the era of ventricular assist devices. J Cardiovasc Elecrophysiol. 2010;1-5.
33. Abuissa H, Roshan J, Lim B, Asirvatham SJ. Use of the impella microaxial blood pump for ablation of hemodynamically unstable ventricular tachycardia. J Cardiovasc Electrophysiol. 2010;21:485-61.
34. Friedman PA, Munger TM, Torres N, Rihal C. Percutaneous endocardial and epicardial ablation of hypotensive ventricular tachycardia with percutaneous left ventricular assist in the electrophysiology laboratory. J Cardiovasc Electrophysiol. 2007;18:106-9. (Pubitemid 44952755)
35. Windecker S. Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock. Curr Opin Crit Care. 2007;13:521-7. (Pubitemid 47357452)
36. Cook S, Windecker S. Percutaneous left ventricular assist devices during cardiogenic shock and high-risk percutaneous coronary interventions. Curr Cardiol Rep. 2009;11:369-76.
37. Farrar DJ, Hill JD, Gray LA, et al. Successful biventricular circulatory support as a bridge to cardiac transplantation during prolonged ventricular fibrillation and asystole. Circulation. 1989;80:147-51. (Pubitemid 19280448)
38. Pennington DG, Reedy JE, Swartz MT, et al. Univentricular versus biventricular assist device support. J Heart Lung Transplant. 1991;10(2):258-63.
39. Oz MC, Rose EA, Slater J, et al. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol. 1994;24(7):1688-91. (Pubitemid 24369194)
40. Harding J, Piacentino III V, Rothman S, et al. Prolonged repolarization after ventricular assist device support is associated with arrhythmias in humans with congestive heart failure. J Card Fail. 2005;11(3):227-32. (Pubitemid 40462427)
41. Andersen M, Videbaek R, Boesgaard S, et al. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant. 2009;28(7):733-5. Ventricular arrhythmias continue to be an issue in patients who have received newer-generation continuous-flow MCS devices. This retrospective study calls attention to the problem, and is one of the few articles assessing ventricular arrhythmias in this growing technology.
42. Bedi M, Kormos R, Winowich S, et al. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol. 2007;99(8):1151-3. (Pubitemid 46562514)
43. Ziv O, Dizon J, Thosani A, et al. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol. 2005;45(9):1428-34. (Pubitemid 40615614)
44. Cantillon DJ, Tarakji KG, Kumbhani DJ, et al. Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm. 2010;7(4):466-71.
45. Dandamudi G, Ghumman WS, Das MK, Miller JM. Endocardial catheter ablation of ventricular tachycardia in patients with ventricular assist devices. Heart Rhythm. 2007;4(9):1165-9. (Pubitemid 47324123)
46. Osaki S, Alberte C, Murray MA, et al. Successful radiofrequency ablation therapy for intractable ventricular tachycardia with a ventricular assist device. J Heart Lung Transplant. 2008;27(3):353-6. (Pubitemid 351375104)
47. Olivari M, Windle J. Cardiac transplantation in patients with refractory ventricular arrhythmias. J Heart Lung Transplant. 2000;19(8):S38-42.